MetaADEDB 2.0 @ LMMD
Bimatoprost
(AQOKCDNYWBIDND-FTOWTWDKSA-N)
Structure
SMILES
CCNC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
Type(s)
Approved; Investigational
ATC code(s)
S01EE03
Molecular Formula:
C25H37NO4
Molecular Weight:
415.566
Log P:
3.5378
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
4
TPSA:
89.79
CAS Number(s):
155206-00-1
Synonym(s)
1.
Bimatoprost
2.
AGN 192024
3.
Latisse
4.
Lumigan
5.
192024, AGN
External Link(s)
MeSHD000069580
PubChem Compound5311027
BindingDB220120
ChEBI51230
CHEMBLCHEMBL1200963
DrugBankDB00905
DrugCentral371
IUPHAR/BPS Guide to PHARMACOLOGY1958
KEGGdr:D02724
Therapeutic Target DatabaseD0Q2XF
ZINC4474405
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 1567
Canada Vigilance: 96
Canada Vigilance
US FAERS
2Eye irritationFAERS: 839
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
3Eyelids pruritusFAERS: 354OFFSIDES
SIDER
US FAERS
4Inappropriate schedule of drug administrationFAERS: 317US FAERS
5Wrong technique in drug usage processFAERS: 304US FAERS
6Eye painFAERS: 276
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
7ErythemaFAERS: 228
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
8TrichorrhexisFAERS: 222
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
9Wrong technique in product usage processFAERS: 211
Canada Vigilance: 3
Canada Vigilance
US FAERS
10Incorrect dose administeredFAERS: 200US FAERS
11Eyelid irritationFAERS: 190OFFSIDES
SIDER
US FAERS
12HypersensitivityFAERS: 188
Canada Vigilance: 1
Canada Vigilance
US FAERS
13Growth of eyelashesFAERS: 177
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
14HeadacheFAERS: 136
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
15PruritusFAERS: 107
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
16Drug administered at inappropriate siteFAERS: 95US FAERS
17Visual ImpairmentFAERS: 86
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
18Drug dose omissionFAERS: 83US FAERS
19BlepharitisFAERS: 75OFFSIDES
SIDER
US FAERS
20Foreign body sensation in eyesFAERS: 70OFFSIDES
US FAERS
21Ocular discomfortFAERS: 68
Canada Vigilance: 1
Canada Vigilance
US FAERS
22Burning sensationFAERS: 65
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
23Eyelid painFAERS: 63SIDER
US FAERS
24Iris hyperpigmentationFAERS: 61
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
25Eye InfectionFAERS: 55OFFSIDES
US FAERS
26Accidental exposure to productFAERS: 53US FAERS
27Product quality issueFAERS: 49
Canada Vigilance: 2
Canada Vigilance
US FAERS
28Expired product administeredFAERS: 48US FAERS
29HordeolumFAERS: 47SIDER
US FAERS
30Skin irritationFAERS: 47US FAERS
31CataractFAERS: 46
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
32DizzinessFAERS: 46
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
33Eyelid exfoliationFAERS: 46US FAERS
34Product dose omissionFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
35Dry skinFAERS: 44SIDER
US FAERS
36PhotophobiaFAERS: 44SIDER
US FAERS
37Application site erythemaFAERS: 42US FAERS
38Product packaging quantity issueFAERS: 42US FAERS
39Drug administration errorFAERS: 41OFFSIDES
US FAERS
40Eyelid margin crustingFAERS: 40SIDER
US FAERS
41Application site painFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
42Dark circles under eyesFAERS: 35US FAERS
43ConjunctivitisFAERS: 34US FAERS
44Inappropriate schedule of product administrationFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
45Product container issueFAERS: 33US FAERS
46Product dropper issueFAERS: 33US FAERS
47AsthenopiaFAERS: 31OFFSIDES
SIDER
US FAERS
48TrichiasisFAERS: 30OFFSIDES
US FAERS
49Application site pruritusFAERS: 28US FAERS
50BlepharospasmFAERS: 26OFFSIDES
SIDER
US FAERS
51Eye inflammationFAERS: 26
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
52Eyelid rashFAERS: 26US FAERS
53GlaucomaFAERS: 25
Canada Vigilance: 2

View details

CTD
OFFSIDES
Canada Vigilance
US FAERS
54DiplopiaFAERS: 24
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
55PainFAERS: 24OFFSIDES
SIDER
US FAERS
56Adverse eventFAERS: 23US FAERS
57BlindnessFAERS: 23US FAERS
58SwellingFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
59Eyelid skin drynessFAERS: 21US FAERS
60Lid sulcus deepenedFAERS: 21US FAERS
61NauseaFAERS: 21
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
62Drug ineffective for unapproved indicationFAERS: 20
Canada Vigilance: 3
Canada Vigilance
US FAERS
63MalaiseFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
64UrticariaFAERS: 20US FAERS
65BlepharopachynsisFAERS: 19US FAERS
66Therapeutic response unexpectedFAERS: 19US FAERS
67Intentional product misuseFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
68Retinal DetachmentFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
69AcneFAERS: 16
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
70Eyelash thickeningFAERS: 16OFFSIDES
US FAERS
71Swelling of eyelidFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
72VertigoFAERS: 16SIDER
US FAERS
73AlopeciaFAERS: 15US FAERS
74Cerebrovascular accidentFAERS: 14US FAERS
75Oropharyngeal painFAERS: 14
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
76Product administered at inappropriate siteFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
77Product storage errorFAERS: 14US FAERS
78Application site irritationFAERS: 13US FAERS
79DermatitisFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
80DysgeusiaFAERS: 13OFFSIDES
US FAERS
81Eyelash changesFAERS: 13US FAERS
82Product physical consistency issueFAERS: 13US FAERS
83Throat irritationFAERS: 13US FAERS
84FatigueFAERS: 12
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
85Feeling abnormalFAERS: 12US FAERS
86MydriasisFAERS: 12US FAERS
87NasopharyngitisFAERS: 12SIDER
US FAERS
88Eyelash hyperpigmentationFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
89Incorrect route of drug administrationFAERS: 11US FAERS
90KeratitisFAERS: 11SIDER
US FAERS
91No adverse eventFAERS: 10US FAERS
92Product use in unapproved indicationFAERS: 10
Canada Vigilance: 5
Canada Vigilance
US FAERS
93Therapy cessationFAERS: 10US FAERS
94Vitreous floatersFAERS: 10SIDER
US FAERS
95AnxietyFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
96Expired drug administeredFAERS: 9US FAERS
97Instillation site painFAERS: 9US FAERS
98Product complaintFAERS: 9US FAERS
99Skin WrinklingFAERS: 9US FAERS
100ArthralgiaFAERS: 8US FAERS
101BronchitisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
102Eye allergyFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
103PalpitationsFAERS: 8SIDER
US FAERS
104Periorbital fat atrophyFAERS: 8US FAERS
105Product packaging issueFAERS: 8US FAERS
106UveitisFAERS: 819403113CTD
SIDER
US FAERS
107Viral upper respiratory tract infectionFAERS: 8US FAERS
108Abdominal discomfortFAERS: 7
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
109AsthmaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
110Eyelash injuryFAERS: 7US FAERS
111Medication ErrorFAERS: 7US FAERS
112Neck PainFAERS: 7US FAERS
113Product label issueFAERS: 7US FAERS
114Product physical issueFAERS: 7US FAERS
115Product use issueFAERS: 7US FAERS
116ScabFAERS: 7US FAERS
117Skin tightnessFAERS: 7US FAERS
118Wrong drug administeredFAERS: 7US FAERS
119Accidental exposureFAERS: 6OFFSIDES
US FAERS
120AstheniaFAERS: 6OFFSIDES
SIDER
US FAERS
121Diabetes MellitusFAERS: 6US FAERS
122Drug effect incompleteFAERS: 6US FAERS
123DysphoniaFAERS: 6OFFSIDES
US FAERS
124Eye RednessFAERS: 6OFFSIDES
US FAERS
125Eyelid infectionFAERS: 6US FAERS
126Facial PainFAERS: 6US FAERS
127Intentional dose omissionFAERS: 6US FAERS
128Lip swellingFAERS: 6US FAERS
129Rash erythematousFAERS: 6US FAERS
130Retinal Vein OcclusionFAERS: 6OFFSIDES
US FAERS
131SinusitisFAERS: 6
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
132SneezingFAERS: 6US FAERS
133TinnitusFAERS: 6US FAERS
134VomitingFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
135Application site rashFAERS: 5US FAERS
136ArthritisFAERS: 5OFFSIDES
SIDER
US FAERS
137Basal cell carcinomaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
138Blood glucose increasedFAERS: 5US FAERS
139Cataract operationFAERS: 5OFFSIDES
US FAERS
140Drug dispensing errorFAERS: 5US FAERS
141EnophthalmosFAERS: 5SIDER
US FAERS
142ExophthalmosFAERS: 5US FAERS
143Eye BurnsFAERS: 5US FAERS
144Incorrect product storageFAERS: 5US FAERS
145InfluenzaFAERS: 5US FAERS
146Macular degenerationFAERS: 5US FAERS
147Ocular icterusFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
148Paranasal sinus hypersecretionFAERS: 5OFFSIDES
US FAERS
149Product counterfeitFAERS: 5US FAERS
150Product use complaintFAERS: 5US FAERS
151Punctate keratitisFAERS: 5SIDER
US FAERS
152Rotator cuff syndromeFAERS: 5US FAERS
153TachycardiaFAERS: 5US FAERS
154AgeusiaFAERS: 4US FAERS
155Application site drynessFAERS: 4US FAERS
156Application site reactionFAERS: 4US FAERS
157Application site swellingFAERS: 4US FAERS
158Atrial FibrillationFAERS: 4US FAERS
159BradycardiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
160ChromaturiaFAERS: 4US FAERS
161Contact lens intoleranceFAERS: 4US FAERS
162Corneal epithelium defectFAERS: 4US FAERS
163EpistaxisFAERS: 4OFFSIDES
US FAERS
164Facial ParesisFAERS: 4US FAERS
165FlushingFAERS: 4US FAERS
166Head discomfortFAERS: 4US FAERS
167HypertrichosisFAERS: 4OFFSIDES
SIDER
US FAERS
168Hypoaesthesia facialFAERS: 4OFFSIDES
US FAERS
169HypotrichosisFAERS: 4US FAERS
170Intraocular pressure fluctuationFAERS: 4OFFSIDES
US FAERS
171IritisFAERS: 4OFFSIDES
SIDER
US FAERS
172LacerationFAERS: 4US FAERS
173Medication residue presentFAERS: 4US FAERS
174Meibomian gland dysfunctionFAERS: 4US FAERS
175MeibomianitisFAERS: 4US FAERS
176Migraine with AuraFAERS: 4US FAERS
177Multiple use of single-use productFAERS: 4US FAERS
178Musculoskeletal PainFAERS: 4US FAERS
179Myocardial InfarctionFAERS: 4US FAERS
180Nasal discomfortFAERS: 4US FAERS
181PregnancyFAERS: 4US FAERS
182Prescription drug used without a prescriptionFAERS: 4US FAERS
183Product container seal issueFAERS: 4US FAERS
184Product prescribing issueFAERS: 4US FAERS
185Reaction to preservativesFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
186Secretion dischargeFAERS: 4US FAERS
187SomnolenceFAERS: 4SIDER
US FAERS
188ThrombosisFAERS: 4US FAERS
189TremorFAERS: 4US FAERS
190AphasiaFAERS: 3US FAERS
191Back PainFAERS: 3US FAERS
192Chest PainFAERS: 3SIDER
US FAERS
193Corneal OpacityFAERS: 3US FAERS
194Corneal dystrophyFAERS: 3US FAERS
195CystFAERS: 3OFFSIDES
US FAERS
196Dacryostenosis acquiredFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
197DyspepsiaFAERS: 3SIDER
US FAERS
198Ear discomfortFAERS: 3US FAERS
199Excessive eye blinkingFAERS: 3US FAERS
200Frustration tolerance decreasedFAERS: 3US FAERS
201Hormone level abnormalFAERS: 3US FAERS
202HypotensionFAERS: 3US FAERS
203InfectionFAERS: 3SIDER
US FAERS
204Instillation site pruritusFAERS: 3US FAERS
205Intentional product use issueFAERS: 3US FAERS
206Liquid product physical issueFAERS: 3US FAERS
207Macular fibrosisFAERS: 3US FAERS
208Mouth swellingFAERS: 3US FAERS
209Muscle tightnessFAERS: 3US FAERS
210MyalgiaFAERS: 3US FAERS
211NervousnessFAERS: 3SIDER
US FAERS
212OverdoseFAERS: 3US FAERS
213Product formulation issueFAERS: 3US FAERS
214Product substitution issueFAERS: 3US FAERS
215RosaceaFAERS: 3US FAERS
216Skin reactionFAERS: 3US FAERS
217Swollen tear ductFAERS: 3US FAERS
218Trigeminal NeuralgiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
219Wrong patient received medicationFAERS: 3US FAERS
220Wrong technique in device usage processFAERS: 3US FAERS
221Accidental exposure to product by childFAERS: 2US FAERS
222Adenoid Cystic CarcinomaFAERS: 2OFFSIDES
US FAERS
223Altered visual depth perceptionFAERS: 2US FAERS
224AmnesiaFAERS: 2US FAERS
225Angina PectorisFAERS: 2US FAERS
226AnosmiaFAERS: 2US FAERS
227Application site exfoliationFAERS: 2US FAERS
228Application site hypersensitivityFAERS: 2US FAERS
229Atrophie blancheFAERS: 2OFFSIDES
US FAERS
230Back disorderFAERS: 2US FAERS
231Blood cholesterol increasedFAERS: 2US FAERS
232Blood creatinine increasedFAERS: 2US FAERS
233BronchospasmFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
234Chest discomfortFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
235ChillsFAERS: 2US FAERS
236Chronotropic incompetenceFAERS: 2US FAERS
237Cluster HeadacheFAERS: 2US FAERS
238ConstipationFAERS: 2US FAERS
239Corneal Endothelial Cell LossFAERS: 2US FAERS
240Corneal InfectionFAERS: 2US FAERS
241Corneal decompensationFAERS: 2US FAERS
242DeafnessFAERS: 2OFFSIDES
US FAERS
243DehydrationFAERS: 2OFFSIDES
US FAERS
244Depressed moodFAERS: 2US FAERS
245DisabilityFAERS: 2US FAERS
246Drug effect delayedFAERS: 2US FAERS
247Ear congestionFAERS: 2US FAERS
248Emotional disorderFAERS: 2US FAERS
249Emotional distressFAERS: 2US FAERS
250Erectile dysfunctionFAERS: 2US FAERS
251Eye complication associated with deviceFAERS: 2US FAERS
252Eye laser surgeryFAERS: 2OFFSIDES
US FAERS
253Facial paralysisFAERS: 2US FAERS
254FolliculitisFAERS: 2US FAERS
255Hypopigmentation of eyelidFAERS: 2US FAERS
256Impaired work abilityFAERS: 2US FAERS
257Incorrect route of product administrationFAERS: 2US FAERS
258InflammationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
259Intraocular pressure test abnormalFAERS: 2US FAERS
260Intraocular pressure testFAERS: 2OFFSIDES
US FAERS
261IridocyclitisFAERS: 2OFFSIDES
US FAERS
262Keratoconjunctivitis SiccaFAERS: 2US FAERS
263LagophthalmosFAERS: 2US FAERS
264LaryngitisFAERS: 2US FAERS
265Limb injuryFAERS: 2US FAERS
266Low density lipoprotein increasedFAERS: 2US FAERS
267Lung cystFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
268LymphadenopathyFAERS: 2US FAERS
269Musculoskeletal stiffnessFAERS: 2US FAERS
270MyopiaFAERS: 2OFFSIDES
US FAERS
271NephrolithiasisFAERS: 2OFFSIDES
US FAERS
272NeuromaFAERS: 2US FAERS
273Nonspecific reactionFAERS: 2US FAERS
274Ocular HypertensionFAERS: 2
Canada Vigilance: 1

View details

CTD
OFFSIDES
Canada Vigilance
US FAERS
275Ocular vascular disorderFAERS: 2US FAERS
276Pain of skinFAERS: 2US FAERS
277PneumoniaFAERS: 2US FAERS
278Prescribed underdoseFAERS: 2US FAERS
279Procedural complicationFAERS: 2US FAERS
280Product lot number issueFAERS: 2US FAERS
281Product prescribing errorFAERS: 2US FAERS
282Product size issueFAERS: 2US FAERS
283Purulent dischargeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
284Scleral pigmentationFAERS: 2US FAERS
285Sinoatrial BlockFAERS: 2US FAERS
286Sinus headacheFAERS: 2US FAERS
287Sinus operationFAERS: 2US FAERS
288StressFAERS: 2US FAERS
289Superficial injury of eyeFAERS: 2US FAERS
290Thermal burnFAERS: 2US FAERS
291TrabeculectomyFAERS: 2OFFSIDES
US FAERS
292Upper respiratory tract irritationFAERS: 2US FAERS
293Urinary IncontinenceFAERS: 2US FAERS
294Urinary tract infectionFAERS: 2US FAERS
295Venous stasisFAERS: 2US FAERS
296Visual brightnessFAERS: 2US FAERS
297Vulvovaginal pruritusFAERS: 2US FAERS
298WheezingFAERS: 2US FAERS
299skin abrasionFAERS: 2US FAERS
300Accidental overdoseFAERS: 1US FAERS
301Acute respiratory failureFAERS: 1US FAERS
302Anal squamous cell carcinomaFAERS: 1US FAERS
303Anaphylactic shockFAERS: 1US FAERS
304Angle Closure GlaucomaFAERS: 1OFFSIDES
US FAERS
305Aortic AneurysmFAERS: 1OFFSIDES
US FAERS
306Application site dischargeFAERS: 1US FAERS
307Application site discomfortFAERS: 1US FAERS
308Application site scabFAERS: 1US FAERS
309Application site scarFAERS: 1US FAERS
310Arcus lipoidesFAERS: 1US FAERS
311ArthropathyFAERS: 1OFFSIDES
US FAERS
312Atypical pneumoniaFAERS: 1US FAERS
313Bacterial VaginosisFAERS: 1US FAERS
314BlepharophimosisFAERS: 1US FAERS
315Borderline glaucomaFAERS: 1US FAERS
316Burning Mouth SyndromeFAERS: 1US FAERS
317Capillary FragilityFAERS: 1US FAERS
318Cardiac FlutterFAERS: 1US FAERS
319Cerebral InfarctionFAERS: 1US FAERS
320Chemical injuryFAERS: 1US FAERS
321ChloasmaFAERS: 1US FAERS
322Choking sensationFAERS: 1OFFSIDES
US FAERS
323CholelithiasisFAERS: 1US FAERS
324Choroidal DetachmentFAERS: 1US FAERS
325ChromatopsiaFAERS: 1OFFSIDES
US FAERS
326Chronic sinusitisFAERS: 1US FAERS
327Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
328Conjunctival pigmentationFAERS: 1US FAERS
329Corneal ScarFAERS: 1US FAERS
330Corneal UlcerFAERS: 1OFFSIDES
US FAERS
331Corneal degenerationFAERS: 1US FAERS
332Corneal erosionFAERS: 1SIDER
US FAERS
333Corneal graft rejectionFAERS: 1US FAERS
334Corneal irritationFAERS: 1US FAERS
335Corneal pigmentationFAERS: 1US FAERS
336Corneal touchFAERS: 1US FAERS
337Counterfeit drug administeredFAERS: 1US FAERS
338CryingFAERS: 1US FAERS
339Cutis LaxaFAERS: 1US FAERS
340CystitisFAERS: 1SIDER
US FAERS
341DacryocanaliculitisFAERS: 1US FAERS
342Deep Vein ThrombosisFAERS: 1US FAERS
343Deformity of orbitFAERS: 1US FAERS
344DeformityFAERS: 1US FAERS
345DeliriumFAERS: 1US FAERS
346Dermoid CystFAERS: 1US FAERS
347Device malfunctionFAERS: 1US FAERS
348DiscomfortFAERS: 1US FAERS
349DisorientationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
350Drug prescribing errorFAERS: 1US FAERS
351EctropionFAERS: 1OFFSIDES
US FAERS
352EczemaFAERS: 1OFFSIDES
US FAERS
353EndophthalmitisFAERS: 1OFFSIDES
US FAERS
354Enlarged uvulaFAERS: 1US FAERS
355Eosinophilic FasciitisFAERS: 1US FAERS
356Excessive skinFAERS: 1US FAERS
357Extra dose administeredFAERS: 1US FAERS
358Extraocular Muscle ParesisFAERS: 1US FAERS
359Eye prosthesis userFAERS: 1US FAERS
360Eye ulcerFAERS: 1US FAERS
361Eyelid Function DisorderFAERS: 1US FAERS
362Eyelid erosionFAERS: 1US FAERS
363Eyelid vellus hair changesFAERS: 1US FAERS
364Face LiftFAERS: 1US FAERS
365Feeling ColdFAERS: 1US FAERS
366FlatulenceFAERS: 1OFFSIDES
US FAERS
367Foaming at mouthFAERS: 1US FAERS
368Food AllergyFAERS: 1US FAERS
369Food PoisoningFAERS: 1US FAERS
370FormicationFAERS: 1OFFSIDES
US FAERS
371FractureFAERS: 1US FAERS
372FrustrationFAERS: 1US FAERS
373Glaucoma surgeryFAERS: 1US FAERS
374Hearing aid userFAERS: 1US FAERS
375Heart alternationFAERS: 1US FAERS
376HirsutismFAERS: 1SIDER
US FAERS
377HypersomniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
378Hypertensive crisisFAERS: 1US FAERS
379HypothyroidismFAERS: 1US FAERS
380Inability to afford medicationFAERS: 1US FAERS
381Incorrect dose administered by productFAERS: 1US FAERS
382Incorrect drug administration durationFAERS: 1US FAERS
383Incorrect drug dosage form administeredFAERS: 1US FAERS
384Increased upper airway secretionFAERS: 1US FAERS
385Increased viscosity of upper respiratory secretionFAERS: 1US FAERS
386Initial insomniaFAERS: 1US FAERS
387Instillation site erythemaFAERS: 1US FAERS
388Instillation site lacrimationFAERS: 1US FAERS
389Intentional device misuseFAERS: 1US FAERS
390Intercepted product prescribing errorFAERS: 1US FAERS
391Joint injuryFAERS: 1OFFSIDES
US FAERS
392Joint swellingFAERS: 1US FAERS
393KeratomileusisFAERS: 1US FAERS
394KeratopathyFAERS: 1US FAERS
395LethargyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
396Lid lagFAERS: 1US FAERS
397Lid margin dischargeFAERS: 1US FAERS
398Limb discomfortFAERS: 1US FAERS
399Limb operationFAERS: 1US FAERS
400LipoatrophyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
401Lipodystrophy acquiredFAERS: 1US FAERS
402Loss of visual contrast sensitivityFAERS: 1US FAERS
403LymphomaFAERS: 1US FAERS
404MaculeFAERS: 1US FAERS
405Manufacturing product shipping issueFAERS: 1US FAERS
406MelanosisFAERS: 1US FAERS
407Memory impairmentFAERS: 1US FAERS
408Middle insomniaFAERS: 1US FAERS
409Mood swingsFAERS: 1US FAERS
410Mucosal painFAERS: 1US FAERS
411Multiple SclerosisFAERS: 1US FAERS
412Nerve injuryFAERS: 1US FAERS
413NeuralgiaFAERS: 1US FAERS
414NeurilemmomaFAERS: 1US FAERS
415NoduleFAERS: 1US FAERS
416Optic NeuritisFAERS: 1US FAERS
417Oral mucosal erythemaFAERS: 1US FAERS
418Oral pruritusFAERS: 1US FAERS
419Orbital cystFAERS: 1US FAERS
420Osteonecrosis of JawFAERS: 1US FAERS
421Otitis MediaFAERS: 1US FAERS
422Packaging design issueFAERS: 1US FAERS
423Panic DisorderFAERS: 1US FAERS
424Peptic UlcerFAERS: 1US FAERS
425Periorbital contusionFAERS: 1US FAERS
426Periorbital disorderFAERS: 1OFFSIDES
US FAERS
427Periorbital swellingFAERS: 1US FAERS
428Pigmentation lipFAERS: 1US FAERS
429PingueculaFAERS: 1US FAERS
430Poor quality product administeredFAERS: 1US FAERS
431Poor quality sleepFAERS: 1US FAERS
432Post procedural complicationFAERS: 1OFFSIDES
US FAERS
433Product availability issueFAERS: 1US FAERS
434Product contaminationFAERS: 1OFFSIDES
US FAERS
435Product contamination microbialFAERS: 1US FAERS
436Product design issueFAERS: 1US FAERS
437Product dispensing errorFAERS: 1US FAERS
438Product distribution issueFAERS: 1US FAERS
439Product label confusionFAERS: 1US FAERS
440Product leakageFAERS: 1US FAERS
441Product preparation errorFAERS: 1US FAERS
442Product shape issueFAERS: 1US FAERS
443Product supply issueFAERS: 1US FAERS
444Productive CoughFAERS: 1US FAERS
445PseudomyopiaFAERS: 1US FAERS
446PterygiumFAERS: 1US FAERS
447Pulmonary thrombosisFAERS: 1US FAERS
448PurpuraFAERS: 1US FAERS
449Renal Cell CarcinomaFAERS: 1US FAERS
450Respiratory distressFAERS: 1US FAERS
451Retinal cystFAERS: 1US FAERS
452Similar reaction on previous exposure to drugFAERS: 1US FAERS
453SinobronchitisFAERS: 1US FAERS
454Sinus painFAERS: 1US FAERS
455Skin PapillomaFAERS: 1US FAERS
456Skin UlcerFAERS: 1US FAERS
457Skin lacerationFAERS: 1US FAERS
458Spinal column stenosisFAERS: 1OFFSIDES
US FAERS
459Stevens-Johnson SyndromeFAERS: 1OFFSIDES
US FAERS
460StomatitisFAERS: 1US FAERS
461SunburnFAERS: 1US FAERS
462Superficial vein prominenceFAERS: 1US FAERS
463SyncopeFAERS: 1US FAERS
464Temporal ArteritisFAERS: 1OFFSIDES
US FAERS
465Therapeutic product ineffective for unapproved indicationFAERS: 1US FAERS
466Therapy non-responderFAERS: 1US FAERS
467Tongue pruritusFAERS: 1US FAERS
468Tooth LossFAERS: 1OFFSIDES
US FAERS
469ToothacheFAERS: 1US FAERS
470Toxic dilatation of intestineFAERS: 1US FAERS
471Toxicity to various agentsFAERS: 1US FAERS
472TracheitisFAERS: 1US FAERS
473TrichomegalyFAERS: 1US FAERS
474TuberculosisFAERS: 1US FAERS
475UlcerFAERS: 1US FAERS
476Unevaluable eventFAERS: 1US FAERS
477Unresponsive to stimuliFAERS: 1OFFSIDES
US FAERS
478Upper-airway cough syndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
479Urine output increasedFAERS: 1US FAERS
480VIIth nerve paralysisFAERS: 1US FAERS
481Visual disturbanceFAERS: 1SIDER
US FAERS
482Vitreous DetachmentFAERS: 1US FAERS
483Vitreous lossFAERS: 1US FAERS
484Weight decreasedFAERS: 1US FAERS
485Wrong product administeredFAERS: 1US FAERS
486cancer surgeryFAERS: 1US FAERS
487furuncleFAERS: 1US FAERS
488treatment failureFAERS: 1US FAERS
489Abnormal visionOFFSIDES
490ActinomycosisOFFSIDES
491AdenocarcinomaOFFSIDES
492AdenomaOFFSIDES
493Alcohol withdrawal syndromeOFFSIDES
494AlveoloplastyOFFSIDES
495AmphetaminesOFFSIDES
496AnhedoniaOFFSIDES
497Animal scratchOFFSIDES
498Ankle FractureOFFSIDES
499AnorexiaOFFSIDES
500AphoniaOFFSIDES
501Aphthous StomatitisOFFSIDES
502AppendicitisOFFSIDES
503AscitesOFFSIDES
504AstigmatismOFFSIDES
505AtaxiaOFFSIDES
506Atrial FlutterOFFSIDES
507Benign Prostatic HyperplasiaOFFSIDES
508Biopsy gingivalOFFSIDES
509Bladder painSIDER
510Blood GlucoseOFFSIDES
511Blood blisterOFFSIDES
512Blood chloride decreasedOFFSIDES
513Blood potassium decreasedOFFSIDES
514Blood thyroid stimulating hormoneOFFSIDES
515Blood zinc decreasedOFFSIDES
516Blunted affectOFFSIDES
517Blurred visionOFFSIDES
518Body fat disorderOFFSIDES
519Bone density decreasedOFFSIDES
520Bone lesionOFFSIDES
521Bone painOFFSIDES
522Budd-Chiari SyndromeOFFSIDES
523Burning sensation in eyeSIDER
524Bursal operationOFFSIDES
525COPD exacerbationSIDER
526CalcinosisOFFSIDES
527Cardioactive drug level increasedOFFSIDES
528Central nervous system lesionOFFSIDES
529Clostridium difficile colitisOFFSIDES
530ClumsinessOFFSIDES
531ColectomyOFFSIDES
532Common ColdSIDER
533ConfabulationOFFSIDES
534Congenital tricuspid valve incompetenceOFFSIDES
535Conjunctival Diseases11448321
16252016
CTD
536Conjunctival blebSIDER
537Conjunctival depositOFFSIDES
538Cor pulmonaleOFFSIDES
539Corneal calcificationSIDER
540Corneal thinningOFFSIDES
541Cutaneous CandidiasisOFFSIDES
542Cyst aspirationOFFSIDES
543CystoceleOFFSIDES
544Dental abscessOFFSIDES
545Dental cariesOFFSIDES
546Device occlusionOFFSIDES
547Diabetic NephropathyOFFSIDES
548Diabetic RetinopathyOFFSIDES
549DiarrheaOFFSIDES
550Diverticular perforationOFFSIDES
551DiverticulitisOFFSIDES
552DiverticulumOFFSIDES
553Drug toxicityOFFSIDES
554Drug withdrawal headacheOFFSIDES
555DyscheziaOFFSIDES
556DysuriaCanada Vigilance: 1Canada Vigilance
557Echocardiogram abnormalOFFSIDES
558Economic problemOFFSIDES
559Electrocardiogram changeOFFSIDES
560Electrocardiogram poor R-wave progressionOFFSIDES
561Endodontic procedureOFFSIDES
562Enterovesical FistulaOFFSIDES
563EntropionOFFSIDES
564Escherichia infectionOFFSIDES
565Escherichia sepsisOFFSIDES
566Exacerbation of asthmaSIDER
567ExcoriationOFFSIDES
568Eyelash darkeningSIDER
569Eyelid DiseasesOFFSIDES
570Facial NeuralgiaOFFSIDES
571Failure to ThriveOFFSIDES
572Femoral pulse decreasedOFFSIDES
573Fistula dischargeOFFSIDES
574Flat affectOFFSIDES
575Fluid overloadOFFSIDES
576Foreign body traumaOFFSIDES
577GastroenteritisOFFSIDES
578Genital dischargeOFFSIDES
579GoiterOFFSIDES
580GoutOFFSIDES
581Graft infectionOFFSIDES
582Hay feverOFFSIDES
583Head titubationOFFSIDES
584Hepatojugular refluxOFFSIDES
585HepatosplenomegalyOFFSIDES
586Hyperemia

View details

CTD
587HyperkeratosisOFFSIDES
588HyperpigmentationOFFSIDES
589Hypertensive heart diseaseOFFSIDES
590HypophagiaOFFSIDES
591Incision site complicationOFFSIDES
592Incision site infectionOFFSIDES
593Instillation site irritationOFFSIDES
SIDER
594Intention tremorOFFSIDES
595Intestinal ObstructionOFFSIDES
596Iron OverloadOFFSIDES
597Keratitis siccaOFFSIDES
598LacrimationSIDER
599Left Ventricular HypertrophyOFFSIDES
600Left atrial dilatationOFFSIDES
601Life expectancy shortenedOFFSIDES
602Listeria sepsisOFFSIDES
603Loose toothOFFSIDES
604Lumbar puncture abnormalOFFSIDES
605LymphedemaOFFSIDES
606Malignant neoplasm progressionOFFSIDES
607MastectomyOFFSIDES
608Maxillofacial operationOFFSIDES
609Medical device complicationOFFSIDES
610Mental status changesOFFSIDES
611MicroalbuminuriaOFFSIDES
612Mixed hepatocellular-cholestatic injuryOFFSIDES
613Muscle WeaknessOFFSIDES
614Muscle abscessOFFSIDES
615Myasthenia GravisOFFSIDES
616MyelodysplasiaOFFSIDES
617Nervous tensionOFFSIDES
618Ocular Hypotension15321024CTD
619Open woundOFFSIDES
620Optic AtrophyOFFSIDES
621Optic NeuropathyOFFSIDES
622OrthopneaOFFSIDES
623OsteomyelitisOFFSIDES
624OsteopeniaOFFSIDES
625OsteoporosisOFFSIDES
626Oxygen supplementationOFFSIDES
627Pancreatic CystOFFSIDES
628Partner stressOFFSIDES
629Pelvic PainCanada Vigilance: 1Canada Vigilance
630Pericardial effusionOFFSIDES
631Periodontal infectionOFFSIDES
632Periodontal operationOFFSIDES
633PeriodontitisOFFSIDES
634Pharmaceutical product complaintOFFSIDES
635PharyngitisSIDER
636Physical disabilityOFFSIDES
637PlasmacytosisOFFSIDES
638Poor quality drug administeredOFFSIDES
639Post procedural cellulitisOFFSIDES
640PresbyopiaOFFSIDES
641Primary sequestrumOFFSIDES
642Pulmonary HypertensionOFFSIDES
643RalesOFFSIDES
644Reflux laryngitisOFFSIDES
645Renal massOFFSIDES
646Renal tubular necrosisOFFSIDES
647Retinal scarOFFSIDES
648RhinalgiaOFFSIDES
649RhinitisSIDER
650RhinorrheaOFFSIDES
651Right atrial dilatationOFFSIDES
652SciaticaCanada Vigilance: 1Canada Vigilance
653ScotomaOFFSIDES
SIDER
654SequestrectomyOFFSIDES
655SeromaOFFSIDES
656Sinus bradycardiaOFFSIDES
657Skin graft failureOFFSIDES
658Splenic InfarctionOFFSIDES
659SpondylolisthesisOFFSIDES
660Squamous cell carcinoma of skinOFFSIDES
661Subcutaneous AbscessOFFSIDES
662Sudden Cardiac DeathOFFSIDES
663Synovial CystOFFSIDES
664SynovitisOFFSIDES
665TenosynovitisOFFSIDES
666TensionSIDER
667Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
668Therapy changeCanada Vigilance: 1Canada Vigilance
669ThyroiditisOFFSIDES
670Tooth ExtractionOFFSIDES
671Uterine PolypOFFSIDES
672Vascular calcificationOFFSIDES
673Vitamin A DeficiencyOFFSIDES
674Vitamin B 12 DeficiencyOFFSIDES
675Vitamin K DeficiencyOFFSIDES
676Vulvovaginal burning sensationCanada Vigilance: 1Canada Vigilance
677Vulvovaginal painCanada Vigilance: 1Canada Vigilance
678Walking aid userOFFSIDES
679Wheelchair userOFFSIDES
680Wound ComplicationOFFSIDES
681diagnostic procedureOFFSIDES
682nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.